Max Wegner
Impact in
-
- Heart Failure Treatment and Management
- Renin-Angiotensin System Studies
- Cardiac Fibrosis and Remodeling
- Cardiovascular Function and Risk Factors
-
- Nitric Oxide and Endothelin Effects
Papers in
-
- Atrial Fibrillation Management and Outcomes 4
- Heart Failure Treatment and Management 2
- Oncology 4
- Peptidase Inhibition and Analysis 3
- Co-authors
- Claudia Hirth‐Dietrich (7 shared papers)Johannes-Peter Stasch (2 shared papers)J.-P. Stasch (2 shared papers)Johannes‐Peter Stasch (2 shared papers)Johannes Peter Stasch (1 shared paper)Detlev Ganten (2 shared papers)Ulf Landmesser (5 shared papers)Julian Friebel (5 shared papers)
- Journals
- Hypertension Research (3 papers)Journal of Cardiovascular Pharmacology (2 papers)Nature Reviews Drug Discovery (2 papers)European Heart Journal (2 papers)Clinical Pharmacology & Therapeutics (2 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Max Wegner
22 papers receiving 307 citations
Peers
Comparison fields: 5 of 81
- Cardiology and Cardiovascular Medicine 148
- Physiology 54
- Endocrinology, Diabetes and Metabolism 33
- Pulmonary and Respiratory Medicine 52
- Internal Medicine 5
Countries citing papers authored by Max Wegner
This map shows the geographic impact of Max Wegner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Wegner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Wegner more than expected).
Fields of papers citing papers by Max Wegner
This network shows the impact of papers produced by Max Wegner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Wegner. The network helps show where Max Wegner may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Wegner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 51 | |
| 2 | 1995 | 46 | |
| 3 | 2013 | 32 | |
| 4 | Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure. | 1996 | 25 |
| 5 | 2019 | 19 | |
| 6 | 1996 | 18 | |
| 7 | 1996 | 15 | |
| 8 | 2020 | 14 | |
| 9 | 2022 | 12 | |
| 10 | 2023 | 11 | |
| 11 | 1995 | 11 | |
| 12 | 1995 | 11 | |
| 13 | 1995 | 10 | |
| 14 | Musik und Tanz | 1968 | 8 |
| 15 | 2023 | 7 | |
| 16 | 2020 | 7 | |
| 17 | 2020 | 6 | |
| 18 | 1996 | 6 | |
| 19 | 1995 | 5 | |
| 20 | 2025 | 4 |
About Max Wegner
Max Wegner is a scholar working on Cardiology and Cardiovascular Medicine, Oncology, Pediatrics, Perinatology and Child Health, Endocrinology, Diabetes and Metabolism and Physiology, having authored 22 papers that have together received 321 indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (4 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Peptidase Inhibition and Analysis (3 papers), Nitric Oxide and Endothelin Effects (2 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Diabetes Treatment and Management (2 papers), Heart Failure Treatment and Management (2 papers) and Pharmaceutical Economics and Policy (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (148 citations), Physiology (54 citations), Endocrinology, Diabetes and Metabolism (33 citations), Pulmonary and Respiratory Medicine (52 citations) and Internal Medicine (5 citations). Max Wegner has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Claudia Hirth‐Dietrich, Johannes-Peter Stasch, J.-P. Stasch, Johannes‐Peter Stasch, Johannes Peter Stasch, Detlev Ganten, Ulf Landmesser, Julian Friebel, D. Dunbar Ivy and Robyn J. Barst. Their work appears in journals such as Hypertension Research, Journal of Cardiovascular Pharmacology, Nature Reviews Drug Discovery, European Heart Journal and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.